|
Jun 11
|
BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD)
|
|
Jun 10
|
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
|
|
Oct 4
|
Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect?
|
|
Oct 4
|
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?
|
|
Oct 1
|
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock?
|
|
Sep 30
|
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners
|
|
Aug 30
|
Here's Why Brainsway Ltd. Sponsored ADR (BWAY) is a Great Momentum Stock to Buy
|
|
Aug 29
|
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
|
|
Aug 26
|
Wall Street Analysts See a 60.85% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
|
|
Jul 25
|
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
|
|
Jul 23
|
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
|
|
Jun 17
|
BrainsWay Expands Global Imprint with Exclusive Multi-Year Distribution Agreement in Canada
|
|
Jun 14
|
BrainsWay (BWAY) to Advance in DEEP TMS for MDD With New Trial
|
|
May 13
|
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 120.45%: Here's is How to Trade
|
|
Jan 10
|
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology
|
|
Dec 27
|
Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect?
|
|
Dec 22
|
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
|
|
Dec 19
|
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network
|
|
Dec 8
|
BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS
|
|
Dec 7
|
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea
|